Dumaine R - Search Results

1

Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial.

Silvain J, Lattuca B, Beygui F, Rangé G, Motovska Z, Dillinger JG, Boueri Z, Brunel P, Lhermusier T, Pouillot C, Larrieu-Ardilouze E, Boccara F, Labeque JN, Guedeney P, El Kasty M, Laredo M, Dumaine R, Ducrocq G, Collet JP, Cayla G, Blanchart K, Kala P, Vicaut E, Montalescot G; ALPHEUS investigators. Silvain J, et al. Among authors: dumaine r. Lancet. 2020 Nov 28;396(10264):1737-1744. doi: 10.1016/S0140-6736(20)32236-4. Epub 2020 Nov 14. Lancet. 2020. PMID: 33202219 Free article. Clinical Trial.

2

Enoxaparin in unstable angina patients who would have been excluded from randomized pivotal trials.

Collet JP, Montalescot G, Fine E, Golmard JL, Dalby M, Choussat R, Ankri A, Dumaine R, Lesty C, Vignolles N, Thomas D. Collet JP, et al. Among authors: dumaine r. J Am Coll Cardiol. 2003 Jan 1;41(1):8-14. doi: 10.1016/s0735-1097(02)02664-5. J Am Coll Cardiol. 2003. PMID: 12570937 Free article.

3

Anti-Xa activity relates to survival and efficacy in unselected acute coronary syndrome patients treated with enoxaparin.

Montalescot G, Collet JP, Tanguy ML, Ankri A, Payot L, Dumaine R, Choussat R, Beygui F, Gallois V, Thomas D. Montalescot G, et al. Among authors: dumaine r. Circulation. 2004 Jul 27;110(4):392-8. doi: 10.1161/01.CIR.0000136830.65073.C7. Epub 2004 Jul 12. Circulation. 2004. PMID: 15249498 Clinical Trial.

4

Prognostic significance of renal insufficiency in patients presenting with acute coronary syndrome (the Prospective Multicenter SYCOMORE study).

Dumaine R, Collet JP, Tanguy ML, Mansencal N, Dubois-Randé JL, Henry P, Steg PG, Michel PL, Allouch P, Cohen A, Colin P, Durand E, Montalescot G; SYCOMORE Investigators. Dumaine R, et al. Am J Cardiol. 2004 Dec 15;94(12):1543-7. doi: 10.1016/j.amjcard.2004.08.035. Am J Cardiol. 2004. PMID: 15589013

5

[Antithrombotics in pre-hospital phase of acute coronary syndromes].

Collet JP, Dumaine R, Ecollan P, Beygui F, Choussat R, Boon G, Payot L, Montalescot G. Collet JP, et al. Among authors: dumaine r. Arch Mal Coeur Vaiss. 2005 Nov;98(11):1118-22. Arch Mal Coeur Vaiss. 2005. PMID: 16379108 Review. French.

6

Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis.

Collet JP, Allali Y, Lesty C, Tanguy ML, Silvain J, Ankri A, Blanchet B, Dumaine R, Gianetti J, Payot L, Weisel JW, Montalescot G. Collet JP, et al. Among authors: dumaine r. Arterioscler Thromb Vasc Biol. 2006 Nov;26(11):2567-73. doi: 10.1161/01.ATV.0000241589.52950.4c. Epub 2006 Aug 17. Arterioscler Thromb Vasc Biol. 2006. PMID: 16917107

7

High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction.

Beygui F, Collet JP, Benoliel JJ, Vignolles N, Dumaine R, Barthélémy O, Montalescot G. Beygui F, et al. Among authors: dumaine r. Circulation. 2006 Dec 12;114(24):2604-10. doi: 10.1161/CIRCULATIONAHA.106.634626. Epub 2006 Nov 20. Circulation. 2006. PMID: 17116769

8

Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials.

Dumaine R, Borentain M, Bertel O, Bode C, Gallo R, White HD, Collet JP, Steinhubl SR, Montalescot G. Dumaine R, et al. Arch Intern Med. 2007 Dec 10;167(22):2423-30. doi: 10.1001/archinte.167.22.2423. Arch Intern Med. 2007. PMID: 18071163 Review.

9

Renal function, atherothrombosis extent, and outcomes in high-risk patients.

Dumaine RL, Montalescot G, Steg PG, Ohman EM, Eagle K, Bhatt DL; REACH Registry Investigators. Dumaine RL, et al. Am Heart J. 2009 Jul;158(1):141-148.e1. doi: 10.1016/j.ahj.2009.05.011. Am Heart J. 2009. PMID: 19540404

10

Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial.

Montalescot G, Zeymer U, Silvain J, Boulanger B, Cohen M, Goldstein P, Ecollan P, Combes X, Huber K, Pollack C Jr, Bénezet JF, Stibbe O, Filippi E, Teiger E, Cayla G, Elhadad S, Adnet F, Chouihed T, Gallula S, Greffet A, Aout M, Collet JP, Vicaut E; ATOLL Investigators. Montalescot G, et al. Lancet. 2011 Aug 20;378(9792):693-703. doi: 10.1016/S0140-6736(11)60876-3. Lancet. 2011. PMID: 21856483 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters